Detalhe da pesquisa
1.
Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.
Bioorg Med Chem
; 98: 117561, 2024 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38157838
2.
Development of dihydropyrrolopyridinone-based PKN2/PRK2 chemical tools to enable drug discovery.
Bioorg Med Chem Lett
; 60: 128588, 2022 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35104640
3.
Discovery of novel benzothiophene derivatives as potent and narrow spectrum inhibitors of DYRK1A and DYRK1B.
Bioorg Med Chem Lett
; 68: 128764, 2022 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35504513
4.
Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancer.
Bioorg Med Chem Lett
; 30(8): 127040, 2020 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32085971
5.
Binding and structural analyses of potent inhibitors of the human Ca2+/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitors.
Sci Rep
; 9(1): 16452, 2019 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31712618
6.
Unsaturated fatty acids as high-affinity ligands of the C-terminal Per-ARNT-Sim domain from the Hypoxia-inducible factor 3α.
Sci Rep
; 5: 12698, 2015 Aug 03.
Artigo
Inglês
| MEDLINE | ID: mdl-26237540